Save your place

Sign in to WhoBought

Please try again later.

Xenetic Biosciences, Inc. (XBIO) institutional ownership

Latest close $2.64 Jul 24, 2026
Market cap$4.1M 52-week range SectorHealthcare
Funds holding · Q2 2023
19
reported XBIO position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q2 2023
Activity unavailable N/A
0 buyers · 19 sellers

Xenetic Biosciences, Inc. (XBIO) price and institutional activity

Dates

Q2 2023

$0 bought by 0 investors
$0 sold by 19 investors
Renaissance Technologies LLCVanguard +17 more
Bought Sold Totals per quarter; hover a bar for the names.

Xenetic Biosciences, Inc. (XBIO) institutional activity · 19

Investor Type Est. change Change Δ Own Date
Renaissance Technologies LLC Exited· Q2 2023 −100K −100.0% Q2 2023
Vanguard · Exited
Change −97K Δ Own −100.0% Date Q2 2023
Vanguard Exited· Q2 2023 −97K −100.0% Q2 2023
Geode · Exited
Change −92K Δ Own −100.0% Date Q2 2023
Geode Exited· Q2 2023 −92K −100.0% Q2 2023
Susquehanna International Group, LLP · Exited
Change −78K Δ Own −100.0% Date Q2 2023
Susquehanna International Group, LLP Exited· Q2 2023 −78K −100.0% Q2 2023
Hrt Financial LP · Exited
Change −37K Δ Own −100.0% Date Q2 2023
Hrt Financial LP Exited· Q2 2023 −37K −100.0% Q2 2023
State Street · Exited
Change −35K Δ Own −100.0% Date Q2 2023
State Street Exited· Q2 2023 −35K −100.0% Q2 2023
Jtc Employer Solutions Trustee Ltd · Exited
Change −27K Δ Own −100.0% Date Q2 2023
Jtc Employer Solutions Trustee Ltd Exited· Q2 2023 −27K −100.0% Q2 2023
Two Sigma Securities, LLC · Exited
Change −20K Δ Own −100.0% Date Q2 2023
Two Sigma Securities, LLC Exited· Q2 2023 −20K −100.0% Q2 2023
Steward Partners Investment Advisory, LLC · Exited
Change −19K Δ Own −100.0% Date Q2 2023
Steward Partners Investment Advisory, LLC Exited· Q2 2023 −19K −100.0% Q2 2023
Northern Trust · Exited
Change −18K Δ Own −100.0% Date Q2 2023
Northern Trust Exited· Q2 2023 −18K −100.0% Q2 2023
Citadel Advisors LLC Exited· Q2 2023 −16K −100.0% Q2 2023
Ergoteles LLC · Exited
Change −13K Δ Own −100.0% Date Q2 2023
Ergoteles LLC Exited· Q2 2023 −13K −100.0% Q2 2023
Tower Research Capital LLC (trc) · Exited
Change −11K Δ Own −100.0% Date Q2 2023
Tower Research Capital LLC (trc) Exited· Q2 2023 −11K −100.0% Q2 2023
Great Valley Advisor Group, Inc. · Exited
Change −11K Δ Own −100.0% Date Q2 2023
Great Valley Advisor Group, Inc. Exited· Q2 2023 −11K −100.0% Q2 2023
Morgan Stanley · Exited
Change −3K Δ Own −100.0% Date Q2 2023
Morgan Stanley Exited· Q2 2023 −3K −100.0% Q2 2023
Data through Q2 2023 · filed Aug 11, 2023
15 of 19

Famous investor activity in Xenetic Biosciences, Inc. (XBIO)

Xenetic Biosciences, Inc. (XBIO) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Parslow James F. · Officer Grant (A) 100K
Owned 100K Trade date Apr 21, 2026 Filed date Apr 23, 2026
Parslow James F. Officer Grant (A) 100K 100K Apr 21, 2026 Apr 23, 2026
Vinogradov Alexey Andreevich · Director Grant (A) 2K
Owned 2K Trade date Dec 31, 2025 Filed date Jan 5, 2026
Vinogradov Alexey Andreevich Director Grant (A) 2K 2K Dec 31, 2025 Jan 5, 2026
Dastoor Firdaus J. · Director Grant (A) 2K
Owned 2K Trade date Dec 31, 2025 Filed date Jan 5, 2026
Dastoor Firdaus J. Director Grant (A) 2K 2K Dec 31, 2025 Jan 5, 2026
Kornberg Roger D. · Director Grant (A) 2K
Owned 2K Trade date Dec 31, 2025 Filed date Jan 5, 2026
Kornberg Roger D. Director Grant (A) 2K 2K Dec 31, 2025 Jan 5, 2026
Borisenko Grigory G. · Director Grant (A) 2K
Owned 2K Trade date Dec 31, 2025 Filed date Jan 5, 2026
Borisenko Grigory G. Director Grant (A) 2K 2K Dec 31, 2025 Jan 5, 2026
5 of 5

Xenetic Biosciences, Inc. (XBIO) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Renaissance Technologies LLC 137K
% of shares outstanding 6.0% Filing date May 14, 2026
Renaissance Technologies LLC 137K 6.0% May 14, 2026
Mjl Manager LLC 94K
% of shares outstanding 4.1% Filing date May 29, 2026
Mjl Manager LLC 94K 4.1% May 29, 2026
2 of 2

Xenetic Biosciences, Inc. (XBIO) ownership FAQ

Who owns XBIO?

19 reporting institutions disclosed XBIO position changes in the Q2 2023 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q2 2023.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.